Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T

Kambiz Nael, B. Mossadeghi, T. Boutelier, W. Kubal, Elizabeth A Krupinski, J. Dagher, J. P. Villablanca

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: DSC perfusion has been increasingly used in conjunction with other contrast-enhanced MR applications and therefore there is need for contrast-dose reduction when feasible. The purpose of this study was to establish the feasibility of reduced-contrast-dose brain DSC perfusion by using a probabilistic Bayesian method and to compare the results with the commonly used singular value decomposition technique. MATERIALS AND METHODS: Half-dose (0.05-mmol/kg) and full-dose (0.1-mmol/kg) DSC perfusion studies were prospectively performed in 20 patients (12 men; 34-70 years of age) by using a 3T MR imaging scanner and a gradient-EPI sequence (TR/TE, 1450/22 ms; flip angle, 90°). All DSC scans were processed with block circulant singular value decomposition and Bayesian probabilistic methods. SNR analysis was performed in both half-dose and full-dose groups. The CBF, CBV, and MTT maps from both full-dose and half-dose scans were evaluated qualitatively and quantitatively in both WM and GM on coregistered perfusion maps. Statistical analysis was performed by using at test, regression, and Bland-Altman analysis. RESULTS: The SNR was significantly (P <.0001) lower in the half-dose group with 32% and 40% reduction in GM and WM, respectively. In the half-dose group, the image-quality scores were significantly higher in Bayesian-derived CBV (P =.02) and MTT (P =.004) maps in comparison with block circulant singular value decomposition. Quantitative values of CBF, CBV, and MTT in Bayesian-processed data were comparable and without a statistically significant difference between the half-dose and full-dose groups. The block circulant singular value decomposition-derived half-dose perfusion values were significantly different from those of the full-dose group both in GM (CBF, P <.001; CBV, P =.02; MTT, P =.02) and WM (CBF, P <.001; CBV, P =.003; MTT, P =.01). CONCLUSIONS: Reduced-contrast-dose (0.05-mmol/kg) DSC perfusion of the brain is feasible at 3T by using the Bayesian probabilistic method with quantitative results comparable with those of the full-dose protocol.

Original languageEnglish (US)
Pages (from-to)710-718
Number of pages9
JournalAmerican Journal of Neuroradiology
Volume36
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Perfusion
Bayes Theorem
Brain

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging

Cite this

Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T. / Nael, Kambiz; Mossadeghi, B.; Boutelier, T.; Kubal, W.; Krupinski, Elizabeth A; Dagher, J.; Villablanca, J. P.

In: American Journal of Neuroradiology, Vol. 36, No. 4, 01.04.2015, p. 710-718.

Research output: Contribution to journalArticle

@article{7dbf2215407c40e4a770fbf8bff3409a,
title = "Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T",
abstract = "BACKGROUND AND PURPOSE: DSC perfusion has been increasingly used in conjunction with other contrast-enhanced MR applications and therefore there is need for contrast-dose reduction when feasible. The purpose of this study was to establish the feasibility of reduced-contrast-dose brain DSC perfusion by using a probabilistic Bayesian method and to compare the results with the commonly used singular value decomposition technique. MATERIALS AND METHODS: Half-dose (0.05-mmol/kg) and full-dose (0.1-mmol/kg) DSC perfusion studies were prospectively performed in 20 patients (12 men; 34-70 years of age) by using a 3T MR imaging scanner and a gradient-EPI sequence (TR/TE, 1450/22 ms; flip angle, 90°). All DSC scans were processed with block circulant singular value decomposition and Bayesian probabilistic methods. SNR analysis was performed in both half-dose and full-dose groups. The CBF, CBV, and MTT maps from both full-dose and half-dose scans were evaluated qualitatively and quantitatively in both WM and GM on coregistered perfusion maps. Statistical analysis was performed by using at test, regression, and Bland-Altman analysis. RESULTS: The SNR was significantly (P <.0001) lower in the half-dose group with 32{\%} and 40{\%} reduction in GM and WM, respectively. In the half-dose group, the image-quality scores were significantly higher in Bayesian-derived CBV (P =.02) and MTT (P =.004) maps in comparison with block circulant singular value decomposition. Quantitative values of CBF, CBV, and MTT in Bayesian-processed data were comparable and without a statistically significant difference between the half-dose and full-dose groups. The block circulant singular value decomposition-derived half-dose perfusion values were significantly different from those of the full-dose group both in GM (CBF, P <.001; CBV, P =.02; MTT, P =.02) and WM (CBF, P <.001; CBV, P =.003; MTT, P =.01). CONCLUSIONS: Reduced-contrast-dose (0.05-mmol/kg) DSC perfusion of the brain is feasible at 3T by using the Bayesian probabilistic method with quantitative results comparable with those of the full-dose protocol.",
author = "Kambiz Nael and B. Mossadeghi and T. Boutelier and W. Kubal and Krupinski, {Elizabeth A} and J. Dagher and Villablanca, {J. P.}",
year = "2015",
month = "4",
day = "1",
doi = "10.3174/ajnr.A4184",
language = "English (US)",
volume = "36",
pages = "710--718",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "4",

}

TY - JOUR

T1 - Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T

AU - Nael, Kambiz

AU - Mossadeghi, B.

AU - Boutelier, T.

AU - Kubal, W.

AU - Krupinski, Elizabeth A

AU - Dagher, J.

AU - Villablanca, J. P.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - BACKGROUND AND PURPOSE: DSC perfusion has been increasingly used in conjunction with other contrast-enhanced MR applications and therefore there is need for contrast-dose reduction when feasible. The purpose of this study was to establish the feasibility of reduced-contrast-dose brain DSC perfusion by using a probabilistic Bayesian method and to compare the results with the commonly used singular value decomposition technique. MATERIALS AND METHODS: Half-dose (0.05-mmol/kg) and full-dose (0.1-mmol/kg) DSC perfusion studies were prospectively performed in 20 patients (12 men; 34-70 years of age) by using a 3T MR imaging scanner and a gradient-EPI sequence (TR/TE, 1450/22 ms; flip angle, 90°). All DSC scans were processed with block circulant singular value decomposition and Bayesian probabilistic methods. SNR analysis was performed in both half-dose and full-dose groups. The CBF, CBV, and MTT maps from both full-dose and half-dose scans were evaluated qualitatively and quantitatively in both WM and GM on coregistered perfusion maps. Statistical analysis was performed by using at test, regression, and Bland-Altman analysis. RESULTS: The SNR was significantly (P <.0001) lower in the half-dose group with 32% and 40% reduction in GM and WM, respectively. In the half-dose group, the image-quality scores were significantly higher in Bayesian-derived CBV (P =.02) and MTT (P =.004) maps in comparison with block circulant singular value decomposition. Quantitative values of CBF, CBV, and MTT in Bayesian-processed data were comparable and without a statistically significant difference between the half-dose and full-dose groups. The block circulant singular value decomposition-derived half-dose perfusion values were significantly different from those of the full-dose group both in GM (CBF, P <.001; CBV, P =.02; MTT, P =.02) and WM (CBF, P <.001; CBV, P =.003; MTT, P =.01). CONCLUSIONS: Reduced-contrast-dose (0.05-mmol/kg) DSC perfusion of the brain is feasible at 3T by using the Bayesian probabilistic method with quantitative results comparable with those of the full-dose protocol.

AB - BACKGROUND AND PURPOSE: DSC perfusion has been increasingly used in conjunction with other contrast-enhanced MR applications and therefore there is need for contrast-dose reduction when feasible. The purpose of this study was to establish the feasibility of reduced-contrast-dose brain DSC perfusion by using a probabilistic Bayesian method and to compare the results with the commonly used singular value decomposition technique. MATERIALS AND METHODS: Half-dose (0.05-mmol/kg) and full-dose (0.1-mmol/kg) DSC perfusion studies were prospectively performed in 20 patients (12 men; 34-70 years of age) by using a 3T MR imaging scanner and a gradient-EPI sequence (TR/TE, 1450/22 ms; flip angle, 90°). All DSC scans were processed with block circulant singular value decomposition and Bayesian probabilistic methods. SNR analysis was performed in both half-dose and full-dose groups. The CBF, CBV, and MTT maps from both full-dose and half-dose scans were evaluated qualitatively and quantitatively in both WM and GM on coregistered perfusion maps. Statistical analysis was performed by using at test, regression, and Bland-Altman analysis. RESULTS: The SNR was significantly (P <.0001) lower in the half-dose group with 32% and 40% reduction in GM and WM, respectively. In the half-dose group, the image-quality scores were significantly higher in Bayesian-derived CBV (P =.02) and MTT (P =.004) maps in comparison with block circulant singular value decomposition. Quantitative values of CBF, CBV, and MTT in Bayesian-processed data were comparable and without a statistically significant difference between the half-dose and full-dose groups. The block circulant singular value decomposition-derived half-dose perfusion values were significantly different from those of the full-dose group both in GM (CBF, P <.001; CBV, P =.02; MTT, P =.02) and WM (CBF, P <.001; CBV, P =.003; MTT, P =.01). CONCLUSIONS: Reduced-contrast-dose (0.05-mmol/kg) DSC perfusion of the brain is feasible at 3T by using the Bayesian probabilistic method with quantitative results comparable with those of the full-dose protocol.

UR - http://www.scopus.com/inward/record.url?scp=84927557081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927557081&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A4184

DO - 10.3174/ajnr.A4184

M3 - Article

C2 - 25430859

AN - SCOPUS:84927557081

VL - 36

SP - 710

EP - 718

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 4

ER -